[BIO Korea 2026 Attendance Insight] 3️⃣ The Era of Open Innovation: How Should Collaboration Between CROs and Bio Startups Change?
페이지 정보
본문
At this year's BIO Korea 2026, an open innovation panel discussion was held with participation from Cha Bio Group, Novartis Korea, Boehringer Ingelheim Korea, and others.
The core message of the discussion was clear: global pharmaceutical companies evaluate "data reliability" just as highly as technological originality. The verifiability and consistency of data as prerequisites for trustworthy data were repeatedly emphasized.
From the perspective of CRO and RWD (Real-World Data) professionals, this message can be interpreted as follows:
✅ Data Quality Management Starting from the Early Stage
Bio startups aiming for global partnerships must establish a data management framework that ensures data standardization, traceability, and reproducibility from the earliest stages of R&D. This is not an afterthought — it is part of the development strategy itself.
✅ Early Establishment of Regulatory Readiness
Clinical entry feasibility, regulatory strategy, and risk management plans must be structured before they ever reach the partnering negotiation table. CROs should not merely act as execution agents in this process — they must serve as strategic advisory partners throughout the entire journey.
✅ The Rise of the One-Stop Commercialization Model
In the pharmaceutical and bio industry, open innovation collaboration models that span the full lifecycle — from R&D through clinical trials, manufacturing, and post-market activities — and that cross company boundaries are expanding. Bidirectional partnerships that combine each party's strengths to create synergies and compensate for each other's weaknesses have become increasingly important.
SeltaSquare is building a data management system with standardized formats and interoperability, working in collaboration with external partners. By connecting clinical trial data and RWD into Real-World Evidence that can be used for regulatory and academic purposes, we aim to establish ourselves as a trusted partner within the open innovation ecosystem.
SeltaSquare will continue to closely monitor changes in the industry and fulfill its role as a specialized organization that provides substantive support for our partners' global expansion.
